Abstract

Antigen presentation is no longer the exclusive domain of cells of hematopoietic origin. Recent works have demonstrated that lymph node stromal cell (LNSC) populations, such as fibroblastic reticular cells, lymphatic and blood endothelial cells, not only provide a scaffold for lymphocyte interactions but also exhibit active immunomodulatory roles that are critical to mounting and resolving effective immune responses. Importantly, LNSCs possess the ability to present antigens and establish antigen-specific interactions with T cells. One example is the expression of peripheral tissue antigens, which are presented on major histocompatibility complex (MHC)-I molecules with tolerogenic consequences on T cells. Additionally, exogenous antigens, including self and tumor antigens, can be processed and presented on MHC-I complexes, which result in dysfunctional activation of antigen-specific CD8+ T cells. While MHC-I is widely expressed on cells of both hematopoietic and non-hematopoietic origins, antigen presentation via MHC-II is more precisely regulated. Nevertheless, LNSCs are capable of endogenously expressing, or alternatively, acquiring MHC-II molecules. Transfer of antigen between LNSC and dendritic cells in both directions has been recently suggested to promote tolerogenic roles of LNSCs on the CD4+ T cell compartment. Thus, antigen presentation by LNSCs is thought to be a mechanism that promotes the maintenance of peripheral tolerance as well as generates a pool of diverse antigen-experienced T cells for protective immunity. This review aims to integrate the current and emerging literature to highlight the importance of LNSCs in immune responses, and emphasize their role in antigen trafficking, retention, and presentation.

Highlights

  • One of the hallmarks of adaptive immunity is the T cell-antigenpresenting cell (APC) crosstalk that takes place in lymph nodes (LNs)

  • This review aims to integrate the current and emerging literature to highlight the importance of Lymph node stromal cells (LNSCs) in immune responses, and emphasize their role in antigen trafficking, retention, and presentation

  • The immunological roles of LNSCs cannot be dissociated from the structural microarchitecture of the LN, albeit in a much more nuanced manner than previously appreciated

Read more

Summary

Introduction

One of the hallmarks of adaptive immunity is the T cell-antigenpresenting cell (APC) crosstalk that takes place in lymph nodes (LNs). LNs constitute particular locations where peripheral tissue environments are sampled in the form of endogenous and exogenous antigens. These processes occur in specific LN regions and are finely controlled by resident stromal cells that promote lymphocyte trafficking and maintain lymphocyte homeostasis. Lymph node stromal cells (LNSCs) constitute a heterogeneous mixture of non-hematopoietic cells (CD45−) of mesenchymal and endothelial origins [2], and have long been appreciated to provide the scaffold on which immune cells encounter antigen [3, 4] Despite their low frequency (

Objectives
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.